2022
DOI: 10.1016/j.bbi.2021.09.016
|View full text |Cite
|
Sign up to set email alerts
|

Increase in plasma CCL11 (Eotaxin-1) in patients with alcohol dependence and changes during detoxification

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 44 publications
1
1
0
Order By: Relevance
“…Circulating CCL11 levels have been shown to be elevated in patients with IBD and are associated with inflammatory disease activity [3,39]. In line with our findings, previous studies have found that chronic alcohol consumption is associated with increased plasma CCL11 levels and is reduced upon alcohol discontinuation [40]. Interestingly, a number of antioxidant substances, including flavonoids, have been shown to suppress eotaxin-1 expression via NFκB-and STAT6-mediated signalling in various human cell lines [41].…”
Section: Discussionsupporting
confidence: 88%
“…Circulating CCL11 levels have been shown to be elevated in patients with IBD and are associated with inflammatory disease activity [3,39]. In line with our findings, previous studies have found that chronic alcohol consumption is associated with increased plasma CCL11 levels and is reduced upon alcohol discontinuation [40]. Interestingly, a number of antioxidant substances, including flavonoids, have been shown to suppress eotaxin-1 expression via NFκB-and STAT6-mediated signalling in various human cell lines [41].…”
Section: Discussionsupporting
confidence: 88%
“…Also, the specificity of CCL11 to SARS-Cov-2 infection needs to be assessed as age-associated cognitive decline and chronic traumatic encephalopathy are associated with elevated CCL11 [ 68 ]. An elevated level of CCL11 is also seen in other pathological states such as asthma [ 69 ], head injuries [ 70 ], and alcohol dependence [ 71 ]. CCL11 levels can be used to stratify patients to assess the risk of their degree of neuroinflammation.…”
Section: Perspectives and Future Directionsmentioning
confidence: 99%